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INTRODUCTION
ABSTRACT
With no current vaccine for Human Immunodeficiency Virus (HIV), it is crucial to study what factors An estimated 37.7 million people are currently living with Human Immunodeficiency Virus (HIV), and this infection has
influence how HIV infects host cells to develop new strategies and therapies to combat this led to 680,000 deaths in 2020 alone (World Health Organization, 2020). HIV hijacks host cells and hinders the innate
pandemic. Cleavage and polyadenylation specificity factor 6 (CPSF6) is an HIV host factor known to immune response. It is important to study what factors influence how HIV infects host cells to develop new strategies
influence HIV infectivity and trafficking early in the infection. CPSF6 has been implicated in supporting and therapies to combat this endemic (Fanales-Belasio et al., 2010). Cleavage and polyadenylation specificity factor 6
the innate immune response but its impact in the context of HIV is unclear. We hypothesize that the (CPSF6) is a host protein that is known to hijack HIV early in the infection. There is no contention that CPSF6 plays a
overexpression of CPSF6 will increase the antiviral response and decrease HIV infection in T cells. To significant role in why HIV-1 infects cells in an effective manner, making this protein noteworthy (Achuthan et al., 2018).
test the hypothesis, we require a way to overexpress CPSF6 in mammalian cells to observe the However, there is debate regarding CPSF6 as the depletion or overexpression of CPSF6 in different cell types renders a
antiviral response of HIV infection. We are going to implement gene cloning, a process used to different impact onto the virus. Preliminary experiments demonstrate that with a knockout of CPSF6 that there is an
replicate DNA for use in later experimentation, to express CPSF6. To make a CPSF6-containing vector, increase in HIV infection and a decrease in the antiviral response. On the other hand, other labs have found that an
we prepared an empty expression mammalian vector through E. coli transformation and plasmid overexpression of CPSF6 leads to a decrease in HIV infection, but there has been no research pointing to the effect that
purification, restriction enzyme digest, and then gel electrophoresis to confirm successful plasmid an overexpression of CPSF6 has on the antiviral response. Therefore, it is imperative to better understand CPSF6's effect
linearization. Post-purification, the CPSF6 gene was then assembled into the empty vector using on the antiviral response in regards to HIV infection.
Gibson Assembly reactions. Successful isolation of the CPSF6 gene-containing plasmid was confirmed
HYPOTHESIS
by Sanger sequencing. Further research will consist of expressing the vector in mammalian cells.
These cells will be tested for their antiviral gene expression by Western blot and infectivity for HIV by We hypothesize that the overexpression of CPSF6 will increase the antiviral response and decrease HIV infection in T
flow cytometry. Ultimately, this experiment will lead to a greater understanding of CPSF6’s role in the cells.
innate immune response in HIV infection.
METHODOLOGY
- Preparation of the Empty Vector for use in Vector Cloning: E. coli transformation and plasmid purification, restriction enzyme digest, and then gel electrophoresis to confirm successful plasmid linearization.
- Creation of full length CPSF6: Gibson Assembly reactions, E. coli transformation and plasmid purification, restriction enzyme digest, and then gel electrophoresis and Sangar Sequencing to confirm successful plasmid creation.
- Amplification and Expression: Midiprep, Transfection, Western Blot
We ultimately require a method to overexpress CPSF6 in mammalian cells to observe the antiviral response in HIV infection.

Figure 1: HIV Lifecycle Schematic
A depiction of the process in which Human Immunodeficiency Virus (HIV)
hijacks a host cell including the role of CPSF6. HIV inserts itself into the host
cell and uses Reverse transcriptase to create more DNA to insert itself into
the genome of the host cell to create more copies of itself

Figure 3: Vector Preparation
An agarose gel showing the results of a restriction
enzyme digest using EcoRI, in which the plasmid was
correctly cut. The red box identifies the uncut plasmid,
and the blue box identifies the linearized plasmid.

Figure 4: CPSF6 Plasmid Map
Plasmid containing CSPF6 inserts with
FLAG tag and puromycin selection marker

Figure 2: CPSF6 Cloning Pipeline
An illustration of the workflow for this project, starting from the preparation of an empty
vector to the detection of CPSF6 in host cells, beginning at the star

Figure 7: Transfection Control
Transfection of green fluorescent protein (GFP)containing plasmid in human cell line as a control for
CPSF6 transfection

Figure 8: Western Blot
Doxycycline inducible CPSF6 transfection in HEK293T human cell line

Figure 5: Restriction Enzyme Digest
An agarose gel showing the results of a restriction enzyme digest of the assembled CPSF6-containing plasmid. The Gibson
Assembly was successful in Lane 2 as outlined by the red box through bands at the 10kb, 1kb, and 0.5kb marks.

CONCLUSIONS
A successful vector construction was made to overexpress CPSF6 in mammalian cells.
FUTURE DIRECTIONS
Future research will determine the effects of overexpression of CPSF6 on HIV-1 infection through flow cytometry, leading to a greater understanding in CPSF6's role in the innate immune response in HIV infection.
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